To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Nanotechnology Breakthrough For IBN
04-26-2005: Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have developed a new method to control both sized and morphology of nanoparticles. The technique, called fluorocarbon-mediated synthesis, is able to produce nanoparticles of 50-300 nm and tuneable pore sizes of 5-30 nm.
"This is the first time that we have been able to control both the size of the particles, as well as the pores. Previously scientists have been successful in only one of the two," said Prof. Jackie Ying, Executive Director of IBN, who worked on the project, with Research Scientist, Dr. Yu Han. Prof. Ying and Dr. Han used a simple wet-chemical technique, to create a variety of nanoparticles with enormous surface areas, and well-defined pore sizes and structures.
"This technique involves the use of two types of surfactant," said Dr. Han. "The tri-block copolymer surfactant act as the supramolecular template for the mesostructure, and did not consider using another surfactant for controlling the particle size and morphology."
IBN's breakthrough was recently featured in the journal Angewandte Chemie. A U.S patent has been filed on the invention and already the institute is in discussion with pharmaceutical companies on using these nanoparticles for various applications. IBN hopes that their invention will be commercialised within the next two years.
One important application is for the production of pure chiral drugs. While these chiral drugs exist in 'left-handed' and 'right-handed' molecules, only one molecule results in a therapeutic effect. Current methods use catalysts to selectively synthesize the preferred molecule. However these catalysts exist in a liquid phase, making it difficult for them to be separated and resued. To solve this problem, Prof Ying's group has developed a novel method, using the nanoparticles created by their technique, to immobilize the catalysts. This turns them into a solid form, which can be easily recovered and reused.
These nanoparticles could be used in a range of other applications, which involve therapeutic treatments like targeted drug delivery or gene therapy. "Ultrafine mesoporous particles would be very useful in catalysis and gas adsorption, since they would provide greater pore accessibility and facilitate molecular diffusion. Because of the presence of nano-sized and tunable pores, these porous nanoparticles could also act as the best matrix for the synthesis of quantum dots and magnetic nanoparticles in functional materials and bioimaging applications. They could also act as carriers for drugs, genes and proteins for novel biomedical applications, since the pore size matches the dimension of these moelcules very well," said Dr. Han.
Watchlist
This is where you can add this news to your personal favourites
- particle size
- morphology
- magnetic nanoparticles
- drug delivery
- diffusion
- Chemie
- 1Arkema speeds up its development in Asia and in green chemistry with the closing of the acquisition of Hipro Polymers and Casda Biomaterials
- 2Bayer CO2 project among best ideas for the future
- 3AkzoNobel further strengthens its global MCA position
- 4BASF increases prices for ethanolamines in Europe
- 5Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 6Former Lufthansa building renamed “LANXESS Tower”
- 7LANXESS expands Jhagadia site to serve booming Indian market
- 8Largest and most efficient BOPP line for Africa
- 9Rhodia and Avantium to jointly develop biobased polyamides
- 10Oxygen molecule survives to enormously high pressures
- 1Baytron P®– Gateway to a new generation of polymers
- 2Rhodia and Avantium to jointly develop biobased polyamides
- 3Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5AkzoNobel selects Tebodin for the conversion of the chlorine plant in Frankfurt
- 6AkzoNobel doubles dimethylether production
- 7Are you certain, Mr. Heisenberg?
- 8BASF invests $50 million to acquire equity ownership position in Sion Power
- 9Bayer MaterialScience commissions new hydrogenation technical center
- 10Illinois Tool Works Inc. acquires AppliChem GmbH
- 1Evonik Industries’ Coatings & Additives announces price increases
- 2Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 3Baytron P®– Gateway to a new generation of polymers
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5Electrochemical extraction of silicon: new approach for a more environmentally friendly large-scale process?
- 6Drew Industrial Division of Ashland Specialty Chemical Company purchases industrial water-treatment business of London-based Fer
- 7LG-DOW Polycarbonate Plant Starts Production in Korea to Effectively Meet Regional Needs
- 8Largest and most efficient BOPP line for Africa
- 9Caflon® surfactants from Univar as substitutes for banned nonylphenol ethoxylates
- 10New study confirms length of immunity conferred by Twinrix®, only combination Hepatitis A and B vaccine
- W. C. Heraeus Becomes Majority Shareholder of Vadnais Technologies Corporation -
- Iberchem announces change in its controlling shareholders -
- Kemira: Tikkurila opens a logistics and customer service center in Mytishchi near Moscow -
- A. Schulman enters into agreement for sale of Orange, Texas plant -
- SDK to Produce Large Area Organic EL Panels, Using Phosphorescent Polymer Technology -
